Stay updated on S 055746 Dose Escalation in AML/MDS Clinical Trial
Sign up to get notified when there's something new on the S 055746 Dose Escalation in AML/MDS Clinical Trial page.

Latest updates to the S 055746 Dose Escalation in AML/MDS Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.3.4 is shown instead of v3.3.3. This appears to be a minor frontend update with no changes to the study details or other important page content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedFooter updates show Revision: v3.3.3; the previous HHS Vulnerability Disclosure link and the v3.3.2 revision note were removed.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page revision label was updated from v3.2.0 to v3.3.2, a metadata change that does not affect study details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedThe government funding/operating status notice was removed from the page; core trial information and sections remain unchanged.SummaryDifference0.4%

- Check73 days agoChange DetectedThe two screenshots show the same study page with no substantive changes; any differences are limited to layout and styling, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check87 days agoChange DetectedRemoved several resource and summary sections (external links, lay summaries, study documents, and drug/device info), reducing access to auxiliary materials and potentially essential content. If no replacements are added, the page becomes more concise but less informative.SummaryDifference1%

Stay in the know with updates to S 055746 Dose Escalation in AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the S 055746 Dose Escalation in AML/MDS Clinical Trial page.